Metalloprotease Meprinβ in Rat Kidney: Glomerular Localization and Differential Expression in Glomerulonephritis by Oneda, Beatrice et al.
Metalloprotease Meprinb in Rat Kidney: Glomerular
Localization and Differential Expression in
Glomerulonephritis
Beatrice Oneda
1., Nade `ge Lods
1., Daniel Lottaz
1¤, Christoph Becker-Pauly
2, Walter Sto ¨cker
2, Jeffrey
Pippin
3, Maya Huguenin
1, Daniel Ambort
1, Hans-Peter Marti
4, Erwin E. Sterchi
1*
1Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland, 2Institute of Zoology, Johannes Gutenberg University, Mainz, Germany,
3Division of Nephrology, University of Washington, Seattle, Washington, United States of America, 4Division of Nephrology/Hypertension, Inselspital, University of Bern,
Bern, Switzerland
Abstract
Meprin (EC 3.4.24.18) is an oligomeric metalloendopeptidase found in microvillar membranes of kidney proximal tubular
epithelial cells. Here, we present the first report on the expression of meprinb in rat glomerular epithelial cells and suggest a
potential involvement in experimental glomerular disease. We detected meprinb in glomeruli of immunostained rat kidney
sections on the protein level and by quantitative RT-PCR of laser-capture microdissected glomeruli on the mRNA level. Using
immuno-gold staining we identified the membrane of podocyte foot processes as the main site of meprinb expression. The
glomerular meprinb expression pattern was altered in anti-Thy 1.1 and passive Heymann nephritis (PHN). In addition, the
meprinb staining pattern in the latter was reminiscent of immunostaining with the sheep anti-Fx1A antiserum, commonly
used in PHN induction. Using Western blot and immunoprecipitation assays we demonstrated that meprinb is recognized
by Fx1A antiserum and may therefore represent an auto-antigen in PHN. In anti-Thy 1.1 glomerulonephritis we observed a
striking redistribution of meprinb in tubular epithelial cells from the apical to the basolateral side and the cytosol. This might
point to an involvement of meprinb in this form of glomerulonephritis.
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Introduction
Many forms of inflammatory kidney disease are characterized
by excessive proliferation of mesangial cells (MC) and by increased
deposition of extracellular matrix (ECM) in glomeruli and the
tubulo-interstitium, with subsequent structural alteration of the
glomerular basement membrane (GBM) and the mesangial matrix
[1,2]. Therefore, an analysis of the factors responsible for the
regulation of MC proliferation and for the metabolism of ECM is
of highest priority. The processing of ECM proteins in the kidney
is influenced substantially by members of the metzincin super-
family of metalloendopeptidases, notably by the matrix metallo-
proteases (MMPs) [3–5] and by the ADAMs (a disintegrin and
metalloprotease) [6,7]. The role of MMPs in basement membrane
remodelling in particular has recently received a lot of attention
due to their ability to influence the progression of renal
dysfunction [8]. Moreover, the pharmacological ablation of
MMP enzymatic activity in a mouse model of Alport syndrome
prior to the onset of proteinuria or structural defects of the GBM
led to significant attenuation in disease progression and to
prolonged survival [9]. Recently, the metalloendopeptidase
meprin has been suggested to be involved in these processes, as
well [10,11]. Meprin (EC 3.4.24.18), an oligomeric zinc
endopeptidase of the astacin family, was originally identified on
the apical brush-border membrane of epithelial cells in the cortico-
medullary portion of proximal kidney tubules and the intestine
[12–15]. It is composed of a and b subunits that are expressed
separately or coordinately either forming homo- or hetero-
oligomeric complexes [16,17]. Meprins are highly conserved
among different species and are capable of cleaving a wide range
of protein substrates in vitro, such as ECM components (collagen
type IV, laminin, fibronectin and nidogen [18–21]), cytokines
(interleukin-1 b), protein kinases, growth factors and peptide
hormones [22–27]. Meprins act extracellularly in that they are
either bound to the plasma membrane by transmembrane
domains or secreted into the extracellular space [28,29].
The role of meprin in the pathogenesis of kidney disease has
been studied previously in animal models. There are mouse strains
(ICR or C57B1/6) that express both meprina and b in proximal
tubular cells and others (C3H/He or CBA) that exclusively express
meprinb, mostly in a latent form (pro-meprinb) with low
proteolytic potential [30]. When exposed to different renal insults,
the latter mice developed less severe forms of kidney disease
compared to those with normal meprin levels, suggesting a
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[31]. Moreover, in a model of ischemia and reperfusion injury,
meprin was reported to be redistributed from the apical brush-
border membrane to the basolateral side and the cytosol of tubular
epithelial cells resulting in degradation of ECM and damage to
adjacent peritubular structures [21]. Recently, it could be shown
that this relocalization occurs also in a mouse model of acute
kidney injury using cisplatin, suggesting that common mechanisms
for meprin redistribution are involved in toxic and ischemic renal
injury [32]. Furthermore, meprin was found to be directly
cytotoxic to cultured tubular epithelial cells and its inhibition by
actinonin and by the metal chelator 1,10-phenanthroline resulted
in a protective effect on cell integrity during ischemia-reperfusion
injury in rats [10,33].
Multiple studies have also revealed that meprin expression is
down-regulated in models of renal injury leading to acute renal
failure. For example, renal damage associated with hydronephrosis
(unilateral urethral obstruction) occurred with an early and
progressive decline in rat meprin subunits on both mRNA and
protein levels [34]. In addition, microarray analysis demonstrated
marked declines in mouse meprinb expression in acute renal
ischemic reperfusion injury and in adriamycin-induced nephrop-
athy [33,35].
In a previous study using a rat model of chronic renal allograft
rejection, we observed a concomitant down-regulation of meprinb
and MMP-9 [36]. MMP-9 has been shown to be secreted by both
mesangial cells and glomerular epithelial cells (podocytes) [37–39].
We therefore decided to check for meprinb expression in
glomeruli and then to further assess meprin regulation in models
of glomerular disease. For this purpose, we focused on meprinb
expression in healthy rat kidney and in two models of rat
glomerular disease: passive Heymann nephritis (PHN), a rat model
of human membranous nephropathy, and anti-Thy 1.1 mesangial
proliferative nephritis [3,40–42]. We demonstrate that a reloca-
lization of the protease occurs following the induction of
glomerular disease, an effect that may contribute to the
pathogenesis of rat glomerulonephritis. Moreover, we demonstrate
that meprin may represents a potential auto-antigen in PHN.
Results
Meprinb expression in podocytes of rat glomeruli
To assess meprinb expression in healthy kidney paraffin-
embedded kidney sections from Wistar rats were analyzed by
immunostaining (Fig. 1). As expected, we observed strong apical
staining of proximal tubular cells (PT) using a specific anti-
meprinb antibody (Fig. 1A, 1E). In addition, glomeruli (G) also
displayed positive meprinb staining (Fig. 1B, 1E). No signal was
observed when the primary meprinb antibody was replaced by
normal rabbit serum (Fig. 1C, 1F), or following pre-incubation
with a five-fold excess of recombinant human meprinb (Fig. 1D).
No effect on signal intensity was seen when the antibody was pre-
incubated with bovine serum albumin (data not shown). We
confirmed these data using Fisher and Lewis rats (supplementary
Figure S1).
To further investigate the localization of meprinb in glomeruli,
we double-stained the Wistar kidney sections with anti-meprinb
antibodies and anti-synaptopodin or anti-Thy 1.1 antibodies
(Fig. 2). Synaptopodin is abundantly expressed in the foot
processes of podocytes whereas Thy 1.1 is localized on the surface
of glomerular mesangial cells. The staining pattern of meprinb
revealed co-localization with synaptopodin (Fig. 2A–C), but not
with Thy 1.1 (Fig. 2D–F). Both meprinb and synaptopodin
displayed a linear staining pattern drawing the contour of the
intra-glomerular capillaries. These findings clearly demonstrate
the expression of meprinb protein in podocytes of rat glomeruli.
mRNA expression of meprinb in glomeruli
Next, we analyzed the mRNA expression by real-time
quantitative RT-PCR (RQ-PCR) on laser-capture microdissected
glomeruli from Wistar rats (Fig. 3). Importantly, the tissue
surrounding the captured glomeruli remained intact following
microdissection (Fig. 3A, 3B). RQ-PCR analyses using 18S RNA
as a house-keeping gene confirmed high meprinb mRNA
expression in glomeruli. The signal of meprinb mRNA derived
from the 200 collected glomeruli was 467-fold higher when
compared to the level of the respective total kidney homogenate
(arbitrarily set as 1.0-fold) (Fig. 3C), explained by the fact that all
glomeruli contribute to meprin expression, while tubular meprinb
is confined to some proximal tubules of the cortico-medullary
section and is therefore diluted in a whole kidney homogenate.
The meprinb mRNA results support the immunostaining data
described above.
Meprinb in experimental PHN
PHN is a rat model of human membranous nephropathy
associated with altered podocyte slit diaphragm integrity, sub-
epithelial immune deposits and expansion of glomerular basal
membranes [43,44]. Analysis of kidney sections from control rats
after injection of normal sheep globulin showed a linear staining
pattern for meprinb. This changed to a granular staining following
injection of anti-Fx1A antiserum to induce PHN (Fig. 4A–C). At
day 3, glomerular capillaries displayed a significant and well
outlined meprinb and synaptopodin staining, whereas at day 6, the
staining intensity became granular and clustered and the overall
picture was less intense in signal strength (Fig. 4B–F and Fig. 4
compare J and K to L), with the granular pattern being more
pronounced for synaptopodin (Fig. 4G, 4H), probably as a result of
a deterioration of podocyte integrity (Fig. 4I).
Detection of meprinb by anti-Fx1a antisera
Since the introduction of PHN as a model for auto-immune
glomerulonephritis [45], a substantial effort was made to identify
responsible antigens. It has been recognized that biologically
relevant antigens must be present in the brush borders of the
proximal kidney tubules as well as in podocyte membranes. PHN
is induced by the administration of sheep or rabbit anti-Fx1A
antisera generated against the brush border membrane fractions of
rat proximal kidney tubules. Meprinb is abundantly expressed in
these membranes but, as shown above, also in glomeruli, the main
target for the antibodies. Moreover, the staining pattern we
observed for meprinb resembled the one obtained by immuno-
staining using anti-Fx1A [46]. Hence, we checked if meprinb was
detected by the anti-Fx1A antiserum using Western blot analysis.
In kidney homogenate from Wistar rats we detected a band of
110-kDa corresponding to the molecular size of meprinb (Fig. 5A,
lane 1). The same band was observed when the blot was stripped
and re-probed with a specific anti-meprinb antibody to show the
specificity of the detection by anti-Fx1A (Fig. 5A, lane 3). In
contrast, no band was detected when the membrane was blotted
with normal serum as a negative control (Fig. 5A, lane 2). A 110-
kDa band corresponding to meprinb was also obtained after
immunoprecipitation using anti-Fx1A antiserum, followed by
Western blot analysis with a specific anti-meprinb antibody
(Fig. 5B, lane 1). No band appeared when the kidney homogenate
was immunoprecipitated with normal serum as a negative control
(Fig. 5B, lane 2). In addition, we stably transfected Madin-Darby
canine kidney (MDCK) cells with human meprinb. Wild-type and
Meprinb in Glomerular Disease
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immunoprecipitation using anti-Fx1A antiserum, followed by
Western blot analysis with anti-meprinb antibody. We obtained
a 110-kDa band in lysates of meprinb-transfected MDCK cells
whereas in wild-type MDCK cells this band was absent (Fig. 5B,
line 3 and 5B, line 4). These findings clearly demonstrate that the
anti-Fx1A antiserum, in addition to other brush border membrane
proteins, detects meprinb. Meprinb could therefore be recognized
at the podocyte membrane by the anti-Fx1A antiserum and thus
contribute to the pathology of PHN as another auto-antigen.
To further strengthen this hypothesis, we analyzed the
subcellular localization of meprinb by immuno-gold labelling of
ultra-thin sections of kidney cortex from adult Wistar rats using the
specific anti-meprinb antibody (Fig. 5C). Gold particles were
Figure 2. Double immunofluorescence staining of kidney sections from Wistar rats. Immunofluorescence staining of glomeruli: (A) anti-
meprinb antibody, (B) anti-synaptopodin antibody, (C) merged image meprin/synaptopodin, (D) anti-meprinb antibody, (E) anti-Thy 1.1 antibody,
(F) merged image meprin/Thy 1.1. Nuclei are marked by staining with 4,6-diamidino-2-phenylindole (DAPI).
doi:10.1371/journal.pone.0002278.g002
Figure 1. Meprinb expression in Wistar rat kidneys. Immunostaining of paraffin embedded kidney tissues from Wistar rats: (A) positive
immunofluorescence staining of proximal tubules and (B) of glomeruli using a specific meprinb antibody. Control immunofluorescence staining: (C)
replacement of the primary antibody with normal rabbit serum. (D) Competitive inhibition of meprinb by pre-incubation with an excess of
recombinant meprinb (r-meprinb). (E) Positive immunohistochemical staining of glomeruli using a specific C-terminal meprinb antibody. Control
immunohistochemical staining: (F) replacement of the primary antibody with normal rabbit serum. G: glomeruli, PT: proximal tubuli. Similar results
were obtained using a different antibody directed against the N-terminal domain of meprinb.
doi:10.1371/journal.pone.0002278.g001
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main processes, facing the urinary space and, to less extent, at the
slit diaphragm. Meprinb, an ectoenzyme, is thus accessible to
circulating antibodies in rat glomeruli and this could lead to the
formation and deposition of immuno-complexes and to the
development of glomerulonephritis.
Meprinb in experimental anti-Thy 1.1 nephritis
Anti-Thy 1.1 nephritis is characterized by an initial phase of
complement-dependent mesangiolysis lasting for approximately 2
days, followed by a marked proliferative response of the residual
mesangial cells associated with the accumulation of ECM [47]. We
observed in preliminary experiments that the latter two features
were reached at day 11 [48]. Therefore, this time point was chosen
for nephrectomy and subsequent meprinb immunostaining (Fig. 6).
We observed a dramatic decrease in meprinb expression in all
glomeruli tested at day 11 after anti-Thy 1.1 injection (Fig. 6B). In
contrast, in control rats injected with PBS we observed normal
meprinb protein levels (Fig. 6A). This observation is in accordance
with the alterations in glomerular structure featuring various
glomerular diseases, particularly at the level of podocytes.
Substantial damage to glomeruli was also reflected by a distorted
synaptopodin staining, indicating loss of podocyte integrity (data
not shown). These changes in protein levels occur along with the
onset of proteinuria, having a maximum around day 2 and 3 after
induction of disease. Moreover, we also noticed a different staining
pattern in proximal tubules: in control rats, a strong signal was
localized at the apical plasma membrane, whereas kidney sections
of nephritic rats displayed a more diffuse staining throughout the
tubular epithelial cells (Fig. 6D–6F). These findings point to a
differential and rapid relocalization of meprinb towards the
basolateral side and the cytoplasm of proximal tubular cells during
mesangioproliferative glomerulonephritis.
Discussion
Meprin comprises approximately 5% of the brush border
membrane in rodent kidney, only second in abundance to actin
[49]. Hence it is considered to be the major protein of the
microvillar membrane with activity for degrading extracellular
matrix proteins [21]. Numerous studies have demonstrated that
renal meprin expression plays a key role in the severity and
progression of renal injury, with meprin exacerbating the disease.
In our study we detected for the first time meprinb expression in
the glomeruli of three different rat strains, a finding expanding our
knowledge on meprin’s previously described expression in the
apical membrane of proximal tubular epithelial cells. Interestingly,
a metalloendopeptidase with a molecular weight corresponding to
that of meprin was previously found in rat glomeruli, but was not
identified [50]. Using specific markers for glomerular cells and
immuno-gold staining we identified the membrane of podocyte
foot processes as the main site of glomerular expression of
meprinb.
In two different rat models of glomerulonephritis we detected
changes in the expression pattern of meprinb, both in the
glomeruli as well as in the proximal tubules. In passive Heymann
nephritis (PHN), the immunofluorescence signal for meprinb in
glomeruli paralleled that of synaptopodin. An increasingly
granular staining was observed indicative of the disruption in
structural integrity of the podocyte foot processes. In addition, the
intensity of meprinb staining was decreased both in the glomeruli
and in the proximal tubules with disease progression. PHN is
induced by the administration of antibodies generated against a
membrane fraction of rat renal proximal tubular cells (sheep or
rabbit anti-Fx1A antibodies), which results in the formation and
deposition of sub-epithelial immune complexes at the glomerular
basement membrane (GBM) [51]. This leads to the disruption of
the functional integrity of the GBM and the filtration barrier,
which in turn results in proteinuria. Megalin, a multiligand
endocytic receptor, localized in the microvillus membrane of
proximal tubular epithelial cells, was previously identified as an
antigen in these immune deposits [52]. The observation of
identical staining patterns with anti-meprinb and anti-rat Fx1A
antibodies [46], the direct detection of meprinb by anti-Fx1A
antibody in Western blots and in immunoprecipitation assays, and
the subcellular localization of meprinb in the membrane of
podocyte foot processes all suggest that meprinb may be involved
in the pathogenesis of PHN by representing another auto-antigen.
The decrease of meprinb immunostaining signal in glomeruli from
rats with PHN may reflect the typical injury of podocytes in this
disease or may reflect a reduced binding affinity of the staining
antibody to the meprinb-immunocomplexes.
Physiologically, the integrity and the structure of the glomerular
basement membrane (GBM) is maintained by the podocytes in a
continuous replacement and recycling effected by proteases [53–
56]. Meprin, expressed by podocytes, may act as such a processing
entity in breaking down GBM components, prior to being
substituted by new matrix proteins. A plethora of ECM
components are processed by meprin in vitro, such as laminin,
collagen IV, nidogen and fibronectin [19–21]. Damage to the
podocytes, either directly in PHN or indirectly through mesangial
injury in Thy 1.1 nephritis, may then interfere with the normal
turnover function of meprin and may thus disturb the steady-state
Figure 3. Relative meprinb mRNA levels of laser-capture
microdissected (LCM) glomeruli from Wistar rats. Two hundred
glomeruli were selected for microdissection with a laser. Kidney cortex
(A) before and (B) following LCM treatment. The tissue surrounding the
captured glomeruli remains intact after microdissection. The presence
of meprinb was confirmed in the microdissected glomeruli by real-time
quantitative PCR (C), and compared with the expression in the total
homogenized kidney. mRNA levels were normalized with 18S as
housekeeping gene.
doi:10.1371/journal.pone.0002278.g003
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the disease.
Thy 1.1 nephritis is a reversible glomerular disease that affects
mesangial cells. We observed a loss of meprinb signal in rat
podocytes at day 11 following induction of the disease. We
postulate that the damage occurring in the mesangial compart-
ment may also lead to changes in podocytes in Thy 1.1 nephritis.
In addition, we observed a marked alteration in meprinb staining
of proximal tubular cells despite the fact that Thy 1.1 nephritis is a
glomerular disease: the immunostaining revealed a shift from a
linear staining confined to the apical brush border membrane in
the corticomedullary junction towards a diffuse cytoplasmatic
staining involving the tubular basement membrane. These findings
are reminiscent of meprinb relocalizations reported in tubular
nephritis such as in hypoxia/reperfusion injury [10,21,31] or in an
acute kidney injury model of cisplatin nephrotoxicity [32]. These
data provide evidence that high levels of meprin are present in
locations other than the apical membrane exposing the protease to
a distinct set of substrates not normally available to meprinb.
These include proteins of the basement membranes and cell-cell
adhesion complexes. It has been shown that mice with low renal
meprin expression levels had less severe forms of structural injury
when compared to mice with higher meprin levels [31,57].
Therefore, expression of meprin in epithelial cells of proximal
tubules appears to be detrimental in an already stressed kidney and
thus worsens the disease course.
This report is to our best knowledge the first to show expression
of the metalloendopeptidase meprinb in rat glomeruli. Moreover,
our results suggest that localization, balance and regulation of
meprinb may constitute features in kidney disease progression. In
order to investigate whether meprinb also has a direct, causal role
in the pathogenesis of glomerulonephritis such as PHN, further
experiments using animal models are needed. Moreover, it will be
interesting to correlate our results with studies in human
glomerulonephritis to assess a role of meprinb as a possible
auto-antigen in membranous nephropathy.
Materials and Methods
Animal tissues
Paraffin-embedded kidney tissues from Fisher and Lewis rat
strains were kindly provided by collaborators in Leiden, The
Netherlands. Approval for the studies was obtained from the local
animal studies commission.
The rats were sacrificed by intra-peritoneal injection of 1 ml of
pentobarbital. After nephrectomy the kidneys were either snap
frozen in liquid nitrogen and stored at -80uC, or fixed for 24 hours
in 5% buffered formalin, de-hydrated and embedded in paraffin.
Induction of disease
Anti-Thy 1.1 nephritis was induced at day 0 in Wistar rats
(150 g body weight) by an intravenous injection of anti-Thy1.1
Figure 4. Meprinb expression in rat glomeruli after induction of Passive Heyman nephritis (PHN). Immunofluorescence staining (A–C) of
meprinb and (D–F) synaptopodin in kidney sections from Sprague-Dawley rats. (G–I) Merged images of meprin/synaptopodin. (J–L)
Immunohistochemical staining of meprinb in glomeruli and in proximal tubules. Staining (A, D, G and J) in control rats, (B, E, H and K) in rats
at day 3 and (C, F, I and L) in rats at day 6 after induction of PHN. A change in distribution of the meprinb in PHN kidneys from a linear to a granular
appearance was observed concomitantly associated with an overall reduction in signal intensity. The distribution of meprinb and synaptopodin in
glomeruli appeared increasingly divergent following progression of PHN.
doi:10.1371/journal.pone.0002278.g004
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described [48]. Kidneys were harvested 11 days after injection,
fixed in formalin and embedded in paraffin.
PHN was induced in male Sprague-Dawley rats (weighing
180 g to 200 g) by intra-peritoneal injection (5 ml/kg body weight)
of sheep anti-Fx1A antibody prepared as described previously
[58,59]. Rats were sacrificed 3 or 6 days after induction of
nephritis.
Immunohistology
Immunohistochemistry of meprinb on rat kidney section was
performed as described previously [36]. Replacement of the
primary antibody with normal rabbit serum served as a control for
the staining specificity (DAKO Diagnostics, Zug, Switzerland).
Immunofluorescence
The paraffin-embedded kidney sections were de-waxed, re-
hydrated and pre-treated by heating in a microwave oven in
10 mM citrate buffer, pH 5.65. Thereafter, sections were washed
with PBS and incubated in 5% bovine serum albumin blocking
solution, before further incubation with the primary antibody for 1
hour at room temperature. Sections were then incubated with
fluorescence labelled secondary antibody for 45 min at room
temperature in the dark, 4,6-diamidino-2-phenylindole (DAPI)
stained for 2 min, mounted in Dako Cytomation Fluorescence-
Mounting Medium and sealed with a cover slip. To prove
specificity of the antisera, we either re-placed the primary
antibodies with normal rabbit serum (DAKO Diagnostic) or we
pre-incubated the primary antibody with recombinant meprinb
(competitive inhibition) [60]. For double labelling, we applied a
second primary antibody for 1 hour. We used the following
antibodies: primary rabbit polyclonal anti-meprinb, targeting
amino acids 468–612 of meprinb, as previously described [61],
primary mouse monoclonal anti-synaptopodin (Progen, Heidel-
berg, Germany), primary monoclonal mouse anti-Thy 1.1 (Oxford
Biotechology, UK), secondary goat anti-rabbit and goat anti-
mouse (Dako Cytomation, Denmark), diluted 1:500, 1:4, 1:20,
1:1000 and 1:400 respectively.
Figure 5. Meprinb is recognized by anti-Fx1A antiserum. (A) Homogenized kidneys from Wistar rats were prepared and analyzed by Western
blotting using sheep anti-Fx1A antiserum (lane 1), normal serum (NS) (lane 2) and meprinb specific antibody (lane 3). A 110-kDa band was detected
using the anti-Fx1A antiserum (lane 1) which corresponds to the meprinb specific band (lane 3). No specific signal was detectable when normal
serum was used as negative control (lane 2). (B) Anti-Fx1A antiserum was used to immunoprecipitate the proteins from homogenized rat kidneys or
from the cell lysates of wild-type and human meprinb-transfected MDCK cells. Normal sheep serum was used instead of anti-Fx1A antiserum as
negative control. Immunoprecipitates were analyzed by Western blots using a specific meprinb antibody. A 110-kDa fragment corresponding to
meprinb was found exclusively in the rat kidney (lane 1) and meprinb-transfected MDCK cell lysates (lane 3) when immunoprecipitation was
performed with anti-Fx1A antisera whereas no band was visualized with normal serum (lane 2). (C) Immuno-gold labeling shows meprinb localization
in podocyte major processes (MP) and foot processes (FP), as indicated by arrows. Meprinb is located in the membrane of the podocyte. GBM:
glomerular basal membrane. CL: capillary lumen.
doi:10.1371/journal.pone.0002278.g005
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Isolated rat kidneys were fixed in 0.1% glutaraldehyde and 3%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 3 hours
at room temperature. Fixed tissue was dehydrated to 96% ethanol,
embedded in LR White hard (Science Services, Munich,
Germany), and polymerized at 4uC under ultraviolet (UV) light
for 48–60 hours. Ultrathin sections (50 nm) were cut on a Leica
Ultracut S and were collected on Formvar-coated nickel grids.
Sections were first etched with saturated sodium periodate (Sigma)
at room temperature for 2 min. The grids were pre-incubated with
0.1% Tween 20 in phosphate-buffered saline (PBS), then blocked
with 50 mM NH4Cl in PBS and in blocking solution (0.5% fish
gelatine (Sigma) plus 0.1% ovalbumin (Sigma) in PBS). Sections
were incubated with primary antibodies against meprinb diluted in
blocking solution at 4uC for 60 hours, washed in PBS and twice in
a mixture of 0.1% ovalbumin, 0.5% cold-water fish gelatin, 0.01%
Tween 20, 0.5 M NaCl in 10 mM phosphate buffer, pH 7.3 (IgG-
gold buffer). The sections were incubated for 2 hours with goat
anti-rabbit Fab conjugated to nanogold
TM (1.4-nm gold particles;
Nanoprobes, Stony Brook, NY), diluted in IgG-gold buffer.
Washed sections were postfixed in 1% glutaraldehyde for 5 min
and air-dried. The nanogold
TM labeling was silver-enhanced for
25 min at room temperature as described [62]. The grids were
then washed in distilled water and stained with 2% ethanolic
uranyl acetate for 10 min and with lead citrate for 2 min before
examination in a FEI Tecnai 12 TEM [63].
Figure 6. Meprinb expression in experimental anti-Thy 1.1 nephritis. Meprinb was detected by immunofluorescence and by
immunohistochemistry in kidney sections (A, C and E) of healthy Wistar rats and (B, D and F) of Wistar rats at day 11 after induction of anti-
Thy 1.1 nephritis. In nephritic rats, meprinb expression is decreased in the glomeruli. Moreover, meprinb expression is not only restricted to the brush
border membrane of the tubules, but is also found diffusely spread within the tubular cells, as indicated by the arrow.
doi:10.1371/journal.pone.0002278.g006
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Kidneys of Wistar rats were embedded individually in
polyethylene glycol freezing media (Tissue-Tek OCT Compound,
Sakura Finetek, Torrance, CA, USA), placed at -20uC for 1 hour
and then stored at 280uC. Tissues were sectioned and mounted
on PALM PEN-covered membrane slides (PALM AG, Bernried,
Germany). LCM was performed immediately after sectioning.
Sections were stained with hematoxylin for 20 s using the
HistoGene Staining Solution (Arcturus HistoGene, LCM Frozen
Section Staining Kit, CA, USA) and dehydrated in graded
solutions of ethanol for 30 s each. Once air-dried, 200 glomeruli
were microdissected and catapulted into PALM adhesive caps
tubes using the laser microdissector pressure catapulting device
(PALM AG, Bernried, Germany). Cells were lysed in RNA
extraction buffer and total RNA was extracted using the PicoPure
RNA Isolation Kit (Arcturus). Total RNA was reverse-transcribed
according to the manufacturer’s instructions (Promega, Catalys
AG, Wallisellen, Switzerland).
Real-time quantitative RT-PCR (RQ-PCR)
cDNA was used as a template for RQ-PCR analysis with the
Applied Biosystems 7500 PCR System according to the manufac-
turer’s protocol in a reaction volume of 20 ml containing 1x
TaqMan Universal PCR Master Mix and 1x TaqMan gene
expression assay (Applied Biosystems Rotkreuz, Switzerland). All
the target genes were measured in duplicates. To detect genomic
DNA contamination, all analyses were also carried out without
reverse transcriptase and without template as negative controls.
18S RNA expression levels served as a housekeeping gene to
normalize expression between different samples and to monitor
assay reproducibility. Relative quantification of all targets was
calculated by the comparative cycle threshold method outlined by
the manufacturer (User Bulletin No. 2; Applied Biosystems).
Immunoblot and immunoprecipitation assay
Homogenized kidney from Wistar rats or cell pellets of the
stably transfected MDCKb and WT [64] were lysed in buffer A
(25 mM Tris/HCl pH 8, 50 mM NaCl) containing 1% deoxy-
cholic acid and 1% Nonidet P-40 in the presence of protease
inhibitors for 30 min on ice. Protein extracts were then denatured
by boiling 5 min with SDS 0.5% followed by electrophoresis on
7.5 or 10% SDS-polyacrylamide gels and transfer to polyvinyli-
dene difluoride membranes (Hybond–P PVDF, Amersham
Biosciences, Uppsala, Sweden). The membranes were saturated
with 5% dry milk and 0.1% Tween-20 in Tris-buffered saline for
2 hours, incubated overnight with the Fx1A antibody (1:1000) or
the specific meprinb antibody (1:2000) and then incubated with
horseradish peroxidase-conjugated anti-sheep IgG (1:5000) for
1.5 hours at room temperature. Immunocomplexes were visual-
ized using the ECL Plus Western blotting kit (Amersham
Biosciences) and X-ray films.
For immunoprecipitation, denatured protein extracts were
incubated with 50 ml of protein G-Sepharose beads conjugated
with the Fx1A antibody for 30 min at 4uC. Immune complexes
were pelleted by microcentrifugation at 15000 g for 5 min at 4uC
and washed 4 times with 0.5% Nonidet P-40, 0.05% deoxycholic
acid and 0.05% SDS in NaCl/Pi. The immunoprecipitate was
then subjected to immunoblotting using anti-meprinb antibodies
as described above.
Supporting Information
Figure S1 Meprinb expression in Fisher and Lewis rat kidneys.
Immunostaining of paraffin-embedded kidney sections (A and C)
from Fisher and (B and D) Lewis rats. Positive staining of
glomeruli and proximal tubules (A and B) in immunohistochemical
sections and (C, D) in immunofluorescence sections using the C-
terminal anti-meprinb antibody.
Found at: doi:10.1371/journal.pone.0002278.s001 (2.15 MB
DOC)
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